Concepts (319)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthroplasty, Replacement, Hip | 77 | 2022 | 749 | 8.270 |
Why?
|
| Arthroplasty, Replacement, Knee | 54 | 2023 | 547 | 6.940 |
Why?
|
| Prosthesis-Related Infections | 29 | 2023 | 173 | 5.280 |
Why?
|
| Hip Prosthesis | 45 | 2022 | 510 | 5.230 |
Why?
|
| Prosthesis Failure | 39 | 2021 | 491 | 3.980 |
Why?
|
| Acetabulum | 17 | 2020 | 221 | 3.230 |
Why?
|
| Reoperation | 65 | 2023 | 847 | 3.050 |
Why?
|
| Knee Prosthesis | 21 | 2023 | 197 | 2.720 |
Why?
|
| Femur | 22 | 2019 | 338 | 2.610 |
Why?
|
| Prosthesis Design | 26 | 2022 | 456 | 2.490 |
Why?
|
| Arthritis, Infectious | 7 | 2023 | 49 | 1.880 |
Why?
|
| Knee Joint | 22 | 2022 | 662 | 1.700 |
Why?
|
| Aged | 75 | 2023 | 8448 | 1.630 |
Why?
|
| Humans | 129 | 2023 | 25165 | 1.580 |
Why?
|
| Osteolysis | 8 | 2015 | 134 | 1.500 |
Why?
|
| Anti-Bacterial Agents | 9 | 2023 | 348 | 1.470 |
Why?
|
| Middle Aged | 69 | 2022 | 8303 | 1.420 |
Why?
|
| Retrospective Studies | 48 | 2023 | 3185 | 1.350 |
Why?
|
| Postoperative Complications | 17 | 2018 | 841 | 1.350 |
Why?
|
| Bone Cements | 7 | 2020 | 78 | 1.340 |
Why?
|
| Male | 79 | 2022 | 13815 | 1.320 |
Why?
|
| Joint Diseases | 6 | 2021 | 103 | 1.300 |
Why?
|
| Female | 76 | 2022 | 14161 | 1.270 |
Why?
|
| Pain, Postoperative | 8 | 2022 | 295 | 1.260 |
Why?
|
| Aged, 80 and over | 46 | 2022 | 4508 | 1.100 |
Why?
|
| Hip Joint | 14 | 2020 | 502 | 1.070 |
Why?
|
| Radiography | 21 | 2019 | 566 | 1.000 |
Why?
|
| Periprosthetic Fractures | 6 | 2019 | 25 | 0.950 |
Why?
|
| Tibia | 10 | 2021 | 207 | 0.930 |
Why?
|
| Bone Resorption | 5 | 2014 | 79 | 0.850 |
Why?
|
| Joint Instability | 8 | 2018 | 353 | 0.840 |
Why?
|
| Vancomycin | 3 | 2018 | 50 | 0.830 |
Why?
|
| Hip Dislocation | 9 | 2016 | 65 | 0.810 |
Why?
|
| Treatment Outcome | 34 | 2023 | 3204 | 0.750 |
Why?
|
| Pelvic Bones | 3 | 2012 | 17 | 0.730 |
Why?
|
| Gentamicins | 2 | 2018 | 17 | 0.720 |
Why?
|
| Tobramycin | 2 | 2018 | 9 | 0.720 |
Why?
|
| Leg Length Inequality | 3 | 2016 | 8 | 0.720 |
Why?
|
| Synovial Fluid | 11 | 2017 | 90 | 0.710 |
Why?
|
| Tantalum | 8 | 2018 | 27 | 0.700 |
Why?
|
| Arthroplasty, Replacement | 2 | 2016 | 140 | 0.690 |
Why?
|
| Follow-Up Studies | 20 | 2019 | 1672 | 0.650 |
Why?
|
| Adult | 39 | 2022 | 7259 | 0.640 |
Why?
|
| Decision Support Techniques | 2 | 2011 | 40 | 0.600 |
Why?
|
| Incidence | 9 | 2018 | 704 | 0.600 |
Why?
|
| Radiostereometric Analysis | 1 | 2018 | 7 | 0.600 |
Why?
|
| Anti-Infective Agents, Local | 2 | 2016 | 45 | 0.590 |
Why?
|
| Population Surveillance | 2 | 2018 | 113 | 0.580 |
Why?
|
| Acute Kidney Injury | 1 | 2018 | 38 | 0.570 |
Why?
|
| Surgical Wound Infection | 2 | 2016 | 80 | 0.570 |
Why?
|
| Osteotomy | 8 | 2014 | 154 | 0.570 |
Why?
|
| Osseointegration | 7 | 2016 | 64 | 0.560 |
Why?
|
| Device Removal | 7 | 2013 | 79 | 0.550 |
Why?
|
| Mupirocin | 1 | 2016 | 16 | 0.520 |
Why?
|
| Bupivacaine | 1 | 2016 | 45 | 0.510 |
Why?
|
| Perioperative Care | 4 | 2017 | 44 | 0.490 |
Why?
|
| Anesthetics, Local | 1 | 2016 | 75 | 0.490 |
Why?
|
| Risk Factors | 12 | 2019 | 2179 | 0.490 |
Why?
|
| Metal-on-Metal Joint Prostheses | 2 | 2015 | 45 | 0.490 |
Why?
|
| Osteoarthritis, Hip | 4 | 2015 | 100 | 0.480 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 2 | 2016 | 112 | 0.470 |
Why?
|
| Femur Head | 2 | 2006 | 62 | 0.470 |
Why?
|
| Metals | 4 | 2015 | 135 | 0.470 |
Why?
|
| Prospective Studies | 9 | 2019 | 1618 | 0.450 |
Why?
|
| Decision Trees | 2 | 2011 | 12 | 0.440 |
Why?
|
| Medical Device Recalls | 1 | 2013 | 1 | 0.430 |
Why?
|
| Dexamethasone | 1 | 2013 | 34 | 0.420 |
Why?
|
| Polymethyl Methacrylate | 2 | 2011 | 11 | 0.420 |
Why?
|
| Bacteremia | 1 | 2013 | 96 | 0.400 |
Why?
|
| Osteoarthritis, Knee | 5 | 2021 | 334 | 0.400 |
Why?
|
| Algorithms | 9 | 2022 | 338 | 0.400 |
Why?
|
| Coated Materials, Biocompatible | 3 | 2014 | 40 | 0.400 |
Why?
|
| Fractures, Bone | 3 | 2013 | 65 | 0.400 |
Why?
|
| Ketamine | 2 | 2022 | 25 | 0.390 |
Why?
|
| Poisoning | 1 | 2012 | 2 | 0.390 |
Why?
|
| Patient Readmission | 1 | 2013 | 118 | 0.390 |
Why?
|
| Antirheumatic Agents | 3 | 2017 | 82 | 0.390 |
Why?
|
| Skin Diseases | 1 | 2012 | 25 | 0.380 |
Why?
|
| United States | 14 | 2022 | 1928 | 0.370 |
Why?
|
| Prostheses and Implants | 2 | 2010 | 147 | 0.370 |
Why?
|
| Patient Satisfaction | 3 | 2019 | 287 | 0.360 |
Why?
|
| Transplantation, Homologous | 7 | 2015 | 237 | 0.360 |
Why?
|
| Orthopedic Surgeons | 2 | 2022 | 24 | 0.350 |
Why?
|
| Biomechanical Phenomena | 8 | 2021 | 593 | 0.340 |
Why?
|
| Demography | 3 | 2019 | 67 | 0.320 |
Why?
|
| Iliac Artery | 1 | 2009 | 5 | 0.320 |
Why?
|
| Foreign-Body Migration | 1 | 2009 | 16 | 0.320 |
Why?
|
| Quality of Life | 2 | 2011 | 594 | 0.310 |
Why?
|
| Elective Surgical Procedures | 3 | 2018 | 33 | 0.310 |
Why?
|
| Recovery of Function | 8 | 2016 | 267 | 0.300 |
Why?
|
| Bone Transplantation | 4 | 2012 | 184 | 0.300 |
Why?
|
| Time Factors | 10 | 2020 | 1336 | 0.290 |
Why?
|
| Rheumatology | 3 | 2017 | 77 | 0.290 |
Why?
|
| Patient Discharge | 1 | 2009 | 137 | 0.290 |
Why?
|
| Surgeons | 4 | 2022 | 79 | 0.280 |
Why?
|
| Arthroplasty | 3 | 2022 | 130 | 0.270 |
Why?
|
| Therapeutic Irrigation | 4 | 2019 | 50 | 0.260 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2011 | 308 | 0.260 |
Why?
|
| C-Reactive Protein | 7 | 2016 | 94 | 0.240 |
Why?
|
| Salmonella arizonae | 1 | 2005 | 1 | 0.240 |
Why?
|
| Cementation | 1 | 2005 | 32 | 0.240 |
Why?
|
| Occupational Diseases | 1 | 2005 | 22 | 0.230 |
Why?
|
| Equipment Failure Analysis | 3 | 2015 | 94 | 0.230 |
Why?
|
| Risk Assessment | 8 | 2018 | 578 | 0.230 |
Why?
|
| Physical Examination | 4 | 2019 | 97 | 0.220 |
Why?
|
| Debridement | 3 | 2013 | 88 | 0.220 |
Why?
|
| Feasibility Studies | 2 | 2018 | 208 | 0.220 |
Why?
|
| Clinical Competence | 2 | 2019 | 182 | 0.210 |
Why?
|
| Cohort Studies | 7 | 2020 | 1772 | 0.210 |
Why?
|
| Spinal Muscular Atrophies of Childhood | 1 | 2003 | 3 | 0.210 |
Why?
|
| Blood Sedimentation | 8 | 2016 | 53 | 0.210 |
Why?
|
| Pain Measurement | 4 | 2016 | 458 | 0.200 |
Why?
|
| Preoperative Care | 5 | 2016 | 108 | 0.200 |
Why?
|
| Medicare | 4 | 2013 | 109 | 0.200 |
Why?
|
| Anesthesia, Conduction | 1 | 2022 | 32 | 0.200 |
Why?
|
| Logistic Models | 3 | 2018 | 377 | 0.200 |
Why?
|
| Foreign Bodies | 1 | 2002 | 26 | 0.190 |
Why?
|
| Biocompatible Materials | 3 | 2017 | 87 | 0.190 |
Why?
|
| Femoral Neck Fractures | 1 | 2022 | 8 | 0.190 |
Why?
|
| Porosity | 5 | 2017 | 58 | 0.190 |
Why?
|
| Femoral Fractures | 2 | 2019 | 34 | 0.190 |
Why?
|
| Postoperative Period | 3 | 2018 | 292 | 0.190 |
Why?
|
| Hemiarthroplasty | 1 | 2022 | 32 | 0.190 |
Why?
|
| Case-Control Studies | 2 | 2018 | 557 | 0.190 |
Why?
|
| Analgesics, Opioid | 2 | 2022 | 215 | 0.180 |
Why?
|
| Odds Ratio | 2 | 2019 | 249 | 0.180 |
Why?
|
| Leukocyte Count | 7 | 2016 | 59 | 0.180 |
Why?
|
| Bone Nails | 1 | 2020 | 13 | 0.180 |
Why?
|
| Arthrodesis | 1 | 2020 | 35 | 0.170 |
Why?
|
| Prescriptions | 1 | 2020 | 15 | 0.170 |
Why?
|
| Glucocorticoids | 2 | 2017 | 64 | 0.170 |
Why?
|
| Tertiary Care Centers | 1 | 2020 | 64 | 0.170 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2019 | 7 | 0.170 |
Why?
|
| Rheumatic Diseases | 2 | 2017 | 53 | 0.160 |
Why?
|
| Illinois | 2 | 2018 | 231 | 0.160 |
Why?
|
| Disease Management | 3 | 2017 | 89 | 0.160 |
Why?
|
| Polyethylene | 2 | 2021 | 119 | 0.160 |
Why?
|
| Treatment Failure | 1 | 2019 | 140 | 0.160 |
Why?
|
| Physician Assistants | 1 | 2019 | 7 | 0.160 |
Why?
|
| Mobile Applications | 1 | 2019 | 28 | 0.150 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 318 | 0.150 |
Why?
|
| Nurse Practitioners | 1 | 2019 | 34 | 0.150 |
Why?
|
| Microspheres | 1 | 2018 | 24 | 0.150 |
Why?
|
| Creatinine | 1 | 2018 | 40 | 0.150 |
Why?
|
| Body Mass Index | 5 | 2020 | 428 | 0.150 |
Why?
|
| Absorption, Physiological | 1 | 2017 | 2 | 0.140 |
Why?
|
| Range of Motion, Articular | 7 | 2020 | 655 | 0.140 |
Why?
|
| Knee | 1 | 2017 | 41 | 0.140 |
Why?
|
| Tendons | 2 | 2012 | 204 | 0.140 |
Why?
|
| Leukocytes | 1 | 2017 | 32 | 0.140 |
Why?
|
| Prosthesis Fitting | 3 | 2011 | 19 | 0.140 |
Why?
|
| Allografts | 2 | 2015 | 192 | 0.140 |
Why?
|
| Registries | 3 | 2022 | 173 | 0.140 |
Why?
|
| Regression Analysis | 1 | 2017 | 251 | 0.140 |
Why?
|
| Orthopedic Procedures | 3 | 2019 | 270 | 0.140 |
Why?
|
| Povidone-Iodine | 2 | 2019 | 4 | 0.130 |
Why?
|
| Biological Products | 1 | 2017 | 34 | 0.130 |
Why?
|
| Self Concept | 1 | 2016 | 36 | 0.130 |
Why?
|
| Kidney | 1 | 2017 | 145 | 0.130 |
Why?
|
| Methicillin | 1 | 2016 | 5 | 0.130 |
Why?
|
| Liposomes | 1 | 2016 | 13 | 0.130 |
Why?
|
| Administration, Intranasal | 1 | 2016 | 24 | 0.130 |
Why?
|
| Immunosuppressive Agents | 1 | 2017 | 114 | 0.130 |
Why?
|
| Methicillin Resistance | 1 | 2016 | 25 | 0.130 |
Why?
|
| Staphylococcal Infections | 2 | 2016 | 150 | 0.130 |
Why?
|
| Nasal Cavity | 1 | 2016 | 32 | 0.130 |
Why?
|
| Staphylococcus aureus | 1 | 2016 | 65 | 0.130 |
Why?
|
| Chlorhexidine | 1 | 2016 | 57 | 0.130 |
Why?
|
| Injections, Intra-Articular | 1 | 2016 | 90 | 0.130 |
Why?
|
| Sleep Wake Disorders | 1 | 2017 | 118 | 0.130 |
Why?
|
| Prevalence | 3 | 2013 | 428 | 0.120 |
Why?
|
| Patella | 2 | 2015 | 67 | 0.120 |
Why?
|
| Cell Count | 1 | 2015 | 73 | 0.120 |
Why?
|
| Ceramics | 1 | 2015 | 19 | 0.120 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 243 | 0.120 |
Why?
|
| Sensitivity and Specificity | 6 | 2015 | 450 | 0.120 |
Why?
|
| Foreign-Body Reaction | 1 | 2015 | 24 | 0.120 |
Why?
|
| Nerve Block | 1 | 2016 | 61 | 0.120 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2018 | 145 | 0.120 |
Why?
|
| Sleep | 1 | 2017 | 290 | 0.110 |
Why?
|
| Intraoperative Complications | 2 | 2013 | 60 | 0.110 |
Why?
|
| Bone Diseases | 2 | 2005 | 21 | 0.110 |
Why?
|
| Length of Stay | 2 | 2013 | 295 | 0.110 |
Why?
|
| Observer Variation | 1 | 2014 | 89 | 0.110 |
Why?
|
| Postoperative Nausea and Vomiting | 1 | 2013 | 16 | 0.110 |
Why?
|
| Decision Making | 2 | 2006 | 202 | 0.110 |
Why?
|
| Awards and Prizes | 1 | 2013 | 18 | 0.110 |
Why?
|
| Insurance, Health | 1 | 2013 | 20 | 0.110 |
Why?
|
| Surveys and Questionnaires | 4 | 2019 | 1085 | 0.110 |
Why?
|
| Random Allocation | 1 | 2013 | 105 | 0.110 |
Why?
|
| Medicaid | 1 | 2013 | 32 | 0.100 |
Why?
|
| Bone Remodeling | 1 | 2013 | 47 | 0.100 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2013 | 77 | 0.100 |
Why?
|
| Tibial Fractures | 1 | 2012 | 6 | 0.100 |
Why?
|
| ROC Curve | 4 | 2016 | 133 | 0.100 |
Why?
|
| Heavy Metal Poisoning | 1 | 2012 | 1 | 0.100 |
Why?
|
| Braces | 1 | 2012 | 23 | 0.100 |
Why?
|
| Reimbursement Mechanisms | 1 | 2012 | 9 | 0.100 |
Why?
|
| Serologic Tests | 1 | 2011 | 9 | 0.090 |
Why?
|
| Predictive Value of Tests | 4 | 2014 | 450 | 0.090 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2012 | 153 | 0.080 |
Why?
|
| Arthritis, Rheumatoid | 3 | 2017 | 251 | 0.080 |
Why?
|
| Suction | 3 | 2015 | 40 | 0.080 |
Why?
|
| Corrosion | 3 | 2015 | 123 | 0.080 |
Why?
|
| Pain Management | 2 | 2022 | 132 | 0.080 |
Why?
|
| Infection Control | 1 | 2011 | 163 | 0.080 |
Why?
|
| Vascular Surgical Procedures | 1 | 2009 | 20 | 0.080 |
Why?
|
| Sepsis | 1 | 2010 | 109 | 0.080 |
Why?
|
| Anesthesia | 1 | 2009 | 29 | 0.080 |
Why?
|
| Ambulatory Care | 1 | 2009 | 66 | 0.080 |
Why?
|
| Preoperative Period | 2 | 2020 | 68 | 0.080 |
Why?
|
| Hip Fractures | 1 | 2008 | 23 | 0.070 |
Why?
|
| Body Weight | 2 | 2019 | 128 | 0.070 |
Why?
|
| Biomarkers | 3 | 2017 | 520 | 0.070 |
Why?
|
| Arthritis, Juvenile | 2 | 2017 | 6 | 0.070 |
Why?
|
| Patient Care Team | 1 | 2009 | 113 | 0.070 |
Why?
|
| Piperidines | 2 | 2017 | 11 | 0.070 |
Why?
|
| Pyrimidines | 2 | 2017 | 14 | 0.070 |
Why?
|
| Pyrroles | 2 | 2017 | 17 | 0.070 |
Why?
|
| Arthritis, Psoriatic | 2 | 2017 | 13 | 0.070 |
Why?
|
| Linear Models | 2 | 2018 | 238 | 0.070 |
Why?
|
| Spondylitis, Ankylosing | 2 | 2017 | 19 | 0.070 |
Why?
|
| Chronic Disease | 2 | 2020 | 397 | 0.070 |
Why?
|
| Age Distribution | 2 | 2005 | 84 | 0.070 |
Why?
|
| Sex Distribution | 2 | 2005 | 78 | 0.070 |
Why?
|
| Guided Tissue Regeneration | 1 | 2006 | 10 | 0.070 |
Why?
|
| Joint Dislocations | 2 | 2018 | 52 | 0.070 |
Why?
|
| Chicago | 3 | 2018 | 916 | 0.070 |
Why?
|
| Surface Properties | 1 | 2006 | 131 | 0.070 |
Why?
|
| Southeastern United States | 1 | 2006 | 13 | 0.060 |
Why?
|
| Neutrophils | 2 | 2017 | 99 | 0.060 |
Why?
|
| Contraindications | 1 | 2006 | 31 | 0.060 |
Why?
|
| Ankle Injuries | 1 | 2005 | 8 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2014 | 836 | 0.060 |
Why?
|
| Salmonella Infections | 1 | 2005 | 1 | 0.060 |
Why?
|
| Markov Chains | 1 | 2005 | 32 | 0.060 |
Why?
|
| Osteogenesis | 1 | 2005 | 101 | 0.060 |
Why?
|
| Animal Husbandry | 1 | 2005 | 7 | 0.060 |
Why?
|
| Graft Survival | 1 | 2005 | 81 | 0.060 |
Why?
|
| Swine | 1 | 2005 | 65 | 0.060 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2017 | 174 | 0.060 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2005 | 105 | 0.060 |
Why?
|
| Databases, Factual | 2 | 2022 | 318 | 0.060 |
Why?
|
| Health Status Indicators | 1 | 2005 | 70 | 0.060 |
Why?
|
| Animals | 3 | 2007 | 3430 | 0.050 |
Why?
|
| Chromium | 2 | 2015 | 84 | 0.050 |
Why?
|
| Cobalt | 2 | 2015 | 107 | 0.050 |
Why?
|
| Titanium | 2 | 2015 | 167 | 0.050 |
Why?
|
| Hospitalization | 1 | 2005 | 284 | 0.050 |
Why?
|
| Tendon Injuries | 1 | 2005 | 191 | 0.050 |
Why?
|
| Young Adult | 3 | 2014 | 1813 | 0.050 |
Why?
|
| Chi-Square Distribution | 2 | 2016 | 126 | 0.050 |
Why?
|
| Polyethylenes | 1 | 2002 | 38 | 0.050 |
Why?
|
| Analgesics | 1 | 2022 | 78 | 0.050 |
Why?
|
| Cost-Benefit Analysis | 1 | 2022 | 114 | 0.050 |
Why?
|
| Comorbidity | 1 | 2003 | 458 | 0.050 |
Why?
|
| Machine Learning | 1 | 2022 | 74 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2003 | 609 | 0.040 |
Why?
|
| Social Class | 1 | 2021 | 64 | 0.040 |
Why?
|
| Statistics, Nonparametric | 2 | 2012 | 120 | 0.040 |
Why?
|
| Recurrence | 2 | 2011 | 274 | 0.040 |
Why?
|
| Benzodiazepines | 1 | 2020 | 45 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2020 | 103 | 0.040 |
Why?
|
| Arthritis | 1 | 2020 | 45 | 0.040 |
Why?
|
| Antidepressive Agents | 1 | 2020 | 94 | 0.040 |
Why?
|
| Survivorship | 1 | 2019 | 22 | 0.040 |
Why?
|
| Fracture Fixation, Internal | 1 | 2019 | 56 | 0.040 |
Why?
|
| Osteoarthritis | 1 | 2003 | 302 | 0.040 |
Why?
|
| Patient Selection | 2 | 2012 | 182 | 0.040 |
Why?
|
| Pain | 1 | 2022 | 384 | 0.040 |
Why?
|
| Child | 1 | 2003 | 1211 | 0.040 |
Why?
|
| Patient Preference | 1 | 2019 | 32 | 0.040 |
Why?
|
| Forecasting | 1 | 2018 | 89 | 0.040 |
Why?
|
| Disease-Free Survival | 1 | 2018 | 142 | 0.040 |
Why?
|
| Spondylarthritis | 1 | 2017 | 3 | 0.040 |
Why?
|
| Cost Savings | 1 | 2017 | 29 | 0.030 |
Why?
|
| Adolescent | 1 | 2003 | 2018 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 39 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 324 | 0.030 |
Why?
|
| Sex Factors | 2 | 2012 | 430 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2017 | 113 | 0.030 |
Why?
|
| Orthopedics | 1 | 2017 | 89 | 0.030 |
Why?
|
| Intraoperative Period | 1 | 2015 | 23 | 0.030 |
Why?
|
| Joints | 1 | 2016 | 63 | 0.030 |
Why?
|
| Geography | 2 | 2005 | 16 | 0.030 |
Why?
|
| Patellar Ligament | 1 | 2015 | 37 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2014 | 58 | 0.030 |
Why?
|
| Operative Time | 1 | 2014 | 86 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2014 | 54 | 0.030 |
Why?
|
| Anthropometry | 1 | 2012 | 32 | 0.030 |
Why?
|
| California | 1 | 2012 | 34 | 0.020 |
Why?
|
| Blood Chemical Analysis | 1 | 2012 | 17 | 0.020 |
Why?
|
| Fees and Charges | 1 | 2012 | 4 | 0.020 |
Why?
|
| Causality | 1 | 2011 | 53 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 641 | 0.020 |
Why?
|
| Wound Closure Techniques | 1 | 2011 | 5 | 0.020 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2011 | 28 | 0.020 |
Why?
|
| Acute Disease | 1 | 2011 | 165 | 0.020 |
Why?
|
| Educational Status | 1 | 2012 | 273 | 0.020 |
Why?
|
| Body Size | 1 | 2010 | 11 | 0.020 |
Why?
|
| Arthralgia | 1 | 2012 | 125 | 0.020 |
Why?
|
| Analgesia | 1 | 2010 | 37 | 0.020 |
Why?
|
| Age Factors | 1 | 2012 | 712 | 0.020 |
Why?
|
| Prognosis | 1 | 2012 | 693 | 0.020 |
Why?
|
| Accidental Falls | 1 | 2010 | 108 | 0.020 |
Why?
|
| Intraoperative Care | 1 | 2008 | 41 | 0.020 |
Why?
|
| Fracture Healing | 1 | 2008 | 25 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 1032 | 0.020 |
Why?
|
| Connective Tissue | 1 | 2007 | 21 | 0.020 |
Why?
|
| Materials Testing | 1 | 2007 | 126 | 0.020 |
Why?
|
| Research | 1 | 2006 | 36 | 0.020 |
Why?
|
| Equipment Design | 1 | 2006 | 132 | 0.020 |
Why?
|
| Medicare Part B | 1 | 2005 | 1 | 0.020 |
Why?
|
| Health Services for the Aged | 1 | 2005 | 6 | 0.020 |
Why?
|
| Walking | 1 | 2008 | 248 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2006 | 199 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2008 | 1301 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2003 | 106 | 0.010 |
Why?
|
| Survival Rate | 1 | 2003 | 290 | 0.010 |
Why?
|